Process Research & Development, Merck & Co., Inc. , Rahway, New Jersey 07065, United States.
Org Lett. 2018 Mar 2;20(5):1265-1268. doi: 10.1021/acs.orglett.7b03639. Epub 2018 Feb 20.
An enantioselective arylation reaction catalyzed by palladium complexed with substituted phosphinooxazoline (PHOX) ligands is described. Aza-quaternary stereocenters are readily accessible through the arylation reaction between cyclic iminosulfates and a wide variety of arylboronic acids, including electron-poor and ortho-substituted arylboronic acids. This reaction was applied to the preparation of verubecestat, which is currently undergoing clinical evaluation for the treatment of Alzheimer's disease.
描述了一种由钯配合取代的膦氧氮杂环戊烷(PHOX)配体催化的对映选择性芳基化反应。通过环状亚氨基硫酸盐与各种芳基硼酸(包括缺电子和邻位取代的芳基硼酸)之间的芳基化反应,易于获得氮杂季碳立体中心。该反应被应用于 verubecestat 的制备,该药物目前正在进行临床试验,用于治疗阿尔茨海默病。